Cipher Pharmaceuticals Inc has seen a stable week in the market, with no significant fluctuations in its stock price.
This week, Cipher Pharmaceuticals Inc (CPH.TO) maintained its position in the market, closing at C$13.65. The stock has remained relatively stable, reflecting a broader trend in the healthcare sector amidst various market conditions.
Advertisement
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$346.92M
P/E
8.9x
52W high
$20.56
52W low
$12.48
1W change
+0.00%
Beta
0.41
Analyst Price Targets
Based on analyst covering CPH · as of Sep 23, 2026
Wall Street analysts forecast CPH stock price to rise 42.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$19.45
+42.5% Upside
Previously C$19.95 on Sep 17, 2026
Current Price
C$13.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
24.0%
Annualized
90-Day Vol
46.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$11.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$12.86 | C$11.84 – C$13.97 |
| 60 trading days | C$12.12 | C$10.78 – C$13.63 |
| 90 trading days | C$11.42 | C$9.89 – C$13.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may want to monitor Cipher Pharmaceuticals' performance closely, especially considering its strong fundamentals, despite recent price stagnation.
Cipher Pharmaceuticals Inc has a P/E ratio of 8.86, indicating potential undervaluation.
With an average analyst target of C$19.45, there is an implied upside of 42.5% from the current price, suggesting positive sentiment among analysts.
Bull case
Cipher Pharmaceuticals boasts a solid profit margin of 58.4% and a return on equity of 23.5%. This strong financial health makes it an appealing choice for long-term investors.
Bear case
However, the stock's current price is significantly below its 50-day and 200-day moving averages, which might signal challenges in gaining upward momentum in the near term.
Price Action
Cipher Pharmaceuticals Inc closed at C$13.65 this week, reflecting a 1-day change of -0.07% and a stagnant week overall with no percentage change. The stock has declined by 3.53% over the past month and is down 8.39% year-to-date.
Company News
Advertisement
This week, Cipher Pharmaceuticals was mentioned in a report highlighting Bright Minds Biosciences and two other Canadian biotech stocks. However, no specific news directly impacting Cipher was released during this period.
Technical Picture
Currently, Cipher Pharmaceuticals is trading below both its 50-day moving average of C$14.69 and its 200-day moving average of C$15.96, which are down 7.1% and 14.5% respectively from the current price. The stock has a 52-week range of C$12.48 to C$20.56, indicating it is currently at 14% of its range. With a beta of 0.41, the stock exhibits lower volatility compared to the broader market.
Insider Activity
No recent insider activity has been reported for Cipher Pharmaceuticals Inc.
Analyst Outlook
Analysts have a bullish outlook on Cipher Pharmaceuticals, with an average target price of C$19.45, suggesting a potential upside of 42.5% from the current trading price. This positive sentiment may indicate confidence in the company's future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
